Rasolofo V, Rasolonavalona T, Ramarokoto H, Chanteau S
Institut Pasteur de Madagascar, Tuberculosis National Reference Laboratory, Antananarivo.
Int J Tuberc Lung Dis. 2000 Feb;4(2):184-5.
The rapid commercialised ICT Tuberculosis test has been tested in Madagascar for the diagnosis of smear-positive pulmonary (SM+) and extra-pulmonary tuberculosis (EPT), using microscopy, culture and histopathology as reference tests. Specificity was 83.3% and sensitivity 68.2% for SM+ patients and 65.2% for EPT patients. With a prevalence of 22.2% for SM+ patients and 52.4% for confirmed EPT among consulting patients in the National Reference Laboratory, the ICT Tuberculosis assay was not sufficiently predictive for application in the tuberculosis control programme.
快速商业化的ICT结核病检测已在马达加斯加进行测试,用于诊断涂片阳性肺结核(SM+)和肺外结核病(EPT),使用显微镜检查、培养和组织病理学作为参考检测方法。对于SM+患者,特异性为83.3%,敏感性为68.2%;对于EPT患者,敏感性为65.2%。在国家参考实验室的咨询患者中,SM+患者的患病率为22.2%,确诊EPT的患病率为52.4%,ICT结核病检测在结核病控制项目中的应用预测性不足。